Canada: Changes In Canadian Institutes Of Health Research Funding: What Will Become Of CIHR Proof Of Principle Commercialization Grants?

Last Updated: June 22 2015
Article by Kathleen Marsman, Ph.D.

Most Read Contributor in Canada, November 2017

As all Canadian health researchers are undoubtedly aware, CIHR is in the throes of reforming the investigator-driven grants program. Major changes are afoot. Gone are the days of investigators gathering from across Canada to cloister themselves together in Ottawa hotel meeting rooms, fueled by mediocre coffee and chicken-wrap sandwiches, pondering the merits of the grant applications of their peers. The new grant review process is primarily electronic, drawing from a pool of reviewers within the newly formed College of Reviewers. Nostalgia for the past and the intangible benefit of these face-to-face gatherings cannot rival the undeniable efficiencies promised by the new scheme.

The previous Open Funding opportunities (primarily operating grants) will be phased out entirely. CIHR operating grants as well as most other themed CIHR grants will be replaced by two new funding schemes: a Foundation Scheme and a Project Scheme. Available money for grants will not be reserved or apportioned to specific technologies within a technologically distinct peer review committee (such as biomedical engineering, cardiovascular, endocrinology, etc), as had previously been the case for review of operating grants applications.

Foundation Scheme grants will fund individual investigators, for a period ranging from 5 to 7 years, with an annual dollar value of $50,000 to $1.5 million. The grants are awarded on the basis of an individual's track record, while taking that person's proposed research into consideration.

Project Scheme grants will fund projects based on the calibre of the proposed idea. The merits of the proposed work, and to some extent the calibre of the individual or team proposing to conduct the work, is evaluated. Project Scheme grants can be proposed for a 1 to 5 year period, with an ask ranging from $50,000 to $750,000.

Pilot competitions for each of the Foundation Scheme and Project Scheme categories are being conducted. Electronic reviews are happening, and interactive on-line discussions are a reality. There is no turning back. Anecdotally, it seems that the enthusiastic banter of the face-to-face discussions is missing from the interactive comments posted in the pilot competitions. Admittedly, these anecdotes are based on a very small sampling of comments from pilot participants as relayed to this author. Nevertheless, it seems that the health researchers have accepted the change, and a willingness to adapt.

There is one small but notable CIHR legacy grant program that has not yet faded into the sunset of the reformation: the Proof of Principle Commercialization Grant Program affectionately known as "PoP", which has funded commercialization grants since 2001. The PoP program has typically run two competitions per year, and will launch the final competition in June 2015 (application deadline: September 2015). In January 2016 this program will lose its individual identity, but CIHR intends to keep a similar the funding opportunity available under the Project Scheme category. The applicants and reviewers who have been integrally involved with the PoP program through the years are hoping that certain aspects of this unique program will be maintained to that research-derived inventions with commercial potential can continue to be eligible for early stage funding, before a commercial partner is identified. The diverse make-up of the review committee, and the unique method for assessing commercial potential in the grant review process, are but two aspects that have distinguished PoP from most other CIHR grants to date.

In the final program launch for the legacy program of PoP grants, two different phases of grants will continue to be offered. Phase I provides up to $160,000 to academic investigators with projects of potential commercial application, if the intellectual property is not yet licensed outside of the originating university. Phase II provides up to $300,000 to academic investigators to match the funds committed by a commercial partner.

The PoP grant program has provided a niche source of funding not only to academic researchers, but also offered advantages to industrial partners collaborating with such researchers through matching partnered grants. Researchers with commercially relevant projects were able to seek funds to ascertain commercial potential, and bring inventions from a more conceptual stage to a more commercially attractive stage with funds made available through this program. Industry stood to benefit from the PoP program because academic researchers could seek matching funds to complement the investment of a committed industry partner, to obtain proof of principle data to further support promising data, effectively doubling the money available to a project. PoP grant recipients have been the investigators to watch, in terms of future commercialization efforts, start-up companies, and industry collaboration efforts.

The last few legacy programs which have not been fully absorbed into the Project Scheme grants are commercialization grants and certain knowledge translation grants. "Knowledge translation" (or KT) is a term that encompasses (among other areas) policy for health care services and the health care system. The PoP grants have developed a tailored application processes, which cannot be replicated in the common Project Scheme application form. For Example, the PoP application asks applicants about what problematic prior art may have been located (known publications or patents that could deter patentability of their invention); whether the applicant believes there is freedom-to-operate for the proposed commercial plan (read: whether other blocking patents are known to exist); and what the commercial landscape looks like (a review of competing technologies). Savvy PoP applicants address regulatory hurdles, market entry barriers, and identify receptor companies, all in the span of the current 14-page limit application.

With the efficiencies of a common application form for all Project Scheme grant applicants, the nuances of information needed to specifically evaluate commercialization potential of a technology may be lost.

In an effort to ensure a smooth transition, CIHR has advised that a minimum funding threshold will be established for commercialization and KT applications (together), once these are absorbed into the Project Scheme. The dedicated community of PoP reviewers, drawn from technology transfer offices, private industry, commercialization specialists, venture capitalists, patent agents, and successful applicants, is making efforts to advise of ways in which commercialization grants can best be evaluated within the Project Scheme by appropriately identified reviewers within the College of Reviewers. PoP applicants in the legacy application process, are able to request funding for up to $32,000 in commercialization activities, including $15,000 for patenting costs. Such funds typically offset the costs of drafting and filing a patent application within the 1-year term of the award, or address ongoing costs of previously filed patent applications. There is a suggestion that such expenses (assuming specific justification) will be permitted as budget items for any application within the Project Scheme.

By bringing commercialization grants into the Project Scheme, CIHR suggests that commercialization per se need not be viewed as a separate and distinct activity from research. Commercialization of research is ready for prime time. If commercialization grants had remained limited to separate and limited budget, perhaps opportunities would be lost. If commercialization expenses become eligible to all applications asserted within the Project Scheme, perhaps more investigators will be encouraged to embrace commercialization as a natural extension of their research program. Commercialization of technologies developed with CIHR funding is an important step in improving the health of Canadians, and others world-wide. With change can come opportunity.

About BLG

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:
  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.
  • Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.
    If you do not want us to provide your name and email address you may opt out by clicking here
    If you do not wish to receive any future announcements of products and services offered by Mondaq you may opt out by clicking here

    Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

    Use of

    You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


    Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

    The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


    Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

    • To allow you to personalize the Mondaq websites you are visiting.
    • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
    • To produce demographic feedback for our information providers who provide information free for your use.

    Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

    Information Collection and Use

    We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

    We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

    Mondaq News Alerts

    In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


    A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

    Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

    Log Files

    We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


    This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

    Surveys & Contests

    From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


    If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


    From time to time Mondaq may send you emails promoting Mondaq services including new services. You may opt out of receiving such emails by clicking below.

    *** If you do not wish to receive any future announcements of services offered by Mondaq you may opt out by clicking here .


    This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

    Correcting/Updating Personal Information

    If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

    Notification of Changes

    If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

    How to contact Mondaq

    You can contact us with comments or queries at

    If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.

    By clicking Register you state you have read and agree to our Terms and Conditions